SlideShare a Scribd company logo
FDA Approval for Medical Devices:
A Guide for Entrepreneurs
Jim Gustafson, Expert in Residence
UCI Applied Innovation
Friday 21 April 2017
Today’s
Outline
1. Our Purpose
2. Who Am I?
3. Basics of Device Regulation in the US
4. Developing a Regulatory Strategy
5. Final Thoughts
6. Questions
1. Our Purpose
What Do
Potential Investors
Want to Know?
 What is your approval pathway?
 How long will it take?
 How much will it cost?
 How likely is success?
Without A Viable Strategy
for Regulatory Approval,
You Will
 Investors will dismiss you.
 FDA will be a roadblock to you.
 Employees will lose faith in you.
 Potential customers will find
someone else to meet their needs.
Today’s Objectives
Provide a basic scaffold to better
understand the regulatory realities
and options for your own situation.
Not to answer all your questions or define a
reg strategy for you. A reg strategy must be
custom-fit to your product, business plan,
customer, competitive landscape, etc.
Academics
BS Biology 1977
University of Minnesota
MS Biology 1978
University of California, Irvine
MA Management 1986
University of Redlands
Mini-MBA 2011
Carnegie-Mellon University, Pittsburgh
Professional
 35+ years in the medical device industry
• Class II and III
• Regulatory Strat, Clin Science, Executive
• 40-plus 510(k)s, PMAs, PMAS, IDEs, CE Marks
• 3 FDA Advisory Panel presentations
• 20-plus multi-center clinical trials in NA and EU
 Last Company: from pre-sales and no approvals to $80M
sales and 20 approvals. In 14 yrs. Sold in 2008 for $361 M.
 Last Title: SVP, Clinical Science and Regulatory Affairs
 Now: Semi-retired indy consultant to med device cos.
• EiR with UCI Applied Innovations
• OCTANe panelist and LauchPad consultant
• Undergrad Mentor, UCI Ayala School of BioSci
3. Basics of Medical Device
Regulation in the US
The Law Requires
• US Medical Devices must be proven
“safe and effective” based on “valid
scientific evidence”.
• Compare to US Drugs: must be proven
“safe and effective” based on “well-
controlled clinical studies”.
• Compare to Devices in the EU: must be
proven “safe and functions as designed”.
Medical Devices are
Regulated Based on Risk
Class Requirements
I 1. General Controls
II
1. General Controls
2. Device-Specific Special Controls
3. Premarket Notification, aka 510(k)
III
1. General Controls
2. Device-Specific Special Controls
3. Premarket Approval, aka PMA
Medical Devices are Regulated
Based on Device Risk
Class Requirements
I 1. General Controls
II
1. General Controls
2. Device-Specific Special Controls
3. Premarket Notification, aka 510(k)
III
1. General Controls
2. Device-Specific Special Controls
3. Premarket Approval, aka PMA
General Controls
• Adulteration
• Misbranding
• Device registration and listing
• Records and reports
• Good Manufacturing Practices (GMPs,
aka Quality System Regulation, or QSR)
Medical Devices are Regulated
Based on Device Risk
Class Requirements
I 1. General Controls
II
1. General Controls
2. Device-Specific Special Controls
3. Premarket Notification, AKA 510(k)
III
1. General Controls
2. Device-Specific Special Controls
3. Premarket Approval, AKA PMA
Special Controls Include
 Independent Standards:
 ISO, ANSI, IEC, ASTM, etc.
 Horizontal Standards
 Vertical Standards
 FDA Guidance Documents
If any of these apply to your product,
use them, or be prepared to explain why not,
and what you used instead, and why.
4. How to Develop a
Successful Regulatory
Approval Strategy
At some point you should
probably talk to your
friendly neighborhood
regulatory consultant.
But you can figure out many
of the key elements yourself!
How? Ask the
Right Questions!
1. Is my product a medical device?
2. What Class is my product in?
3. What is my pathway to approval?
4. Will clinical studies be needed?
5. What are the strategic implications
of the pathway?
Is My Product a
Medical Device?
An instrument, apparatus, implement, machine, contrivance,
implant, in vitro reagent, or other similar or related article,
component, or accessory which is:
1. Intended to diagnosis disease or other conditions; or
2. Intended to cure, mitigate, treat, or prevent disease; or
3. Intended to affect the structure or any function of the body;
4. And which does not achieve any of its primary intended
purposes through chemical action,
5. And does not depend on being metabolized to achieve them.
The Border May
be Set by Claims
and Intended Use
Example: A wearable that counts footsteps or
calories, but claims no medical benefit from doing
so, is NOT a medical device.
The same product doing the same thing but with
the claim that doing so helps the user lose weight
or lower blood pressure IS a medical device.
What Class is
My Product?
• Go to FDA > Medical Devices >
Data Bases > Product Classification
(https://www.accessdata.fda.gov/scripts/cdrh/cf
docs/cfPCD/PCDSimpleSearch.cfm)
• Type in the name of your product.
• Review the listing.
• Iterate until you find the most accurate
description.
Product Classification Page
Example: Drug Eluting Stent
Example: Surgical Scissors
Example: IVUS Catheter
What Is My
Approval Pathway?
Class Level of Proof FDA Filing*
Testing
Needed*
I
Mfg Registration
and Device Listing
Bench
II
Substantial
Equivalence
510(k)
Bench
Animal
III Safe and Effective PMA
Bench
Animal
Human
*Some Exceptions
Is My Device a 510(k)?
Almost all Class II devices are! But how to know?
• Check out similar devices on the FDA Product
Listing page
• Find 510(k)s for similar devices at FDA >
Medical Devices > Database > 510(k)s
• Is there a device, itself under 510(k), to which
you can prove substantial equivalence (SE)?
• You can’t claim SE to a PMA device.
What Makes for SE? (1/2)
Compared to the Proposed Predicate Device:
• Same intended use and same technological
characteristics; or
• Same intended use and different technological
characteristics, but that do not raise new
questions of safety and effectiveness, with
supporting evidence that the new device is at
least as safe and effective as the predicate.
What Makes for SE? (2/2)
SE does not mean the 2 devices are
identical. SE is judged base on intended
use, design, energy used or delivered,
materials, chemical composition,
manufacturing process, performance,
safety, effectiveness, labeling,
biocompatibility, standards, etc.
SE is Kind of
a Black Art
• The closer to your proposed predicate on each
of these, the more likely you will succeed.
• But there is no hard rule, guidance!
• FDA will not tell you; you must make your case
in a 510(k) filing!
• In FDA’s response, you will know.
• One key: how far is your predicate from its?
SE
If Not 510(k), Then It’s PMA
Class Level of Proof FDA Filing*
Testing
Needed*
I
Mfg Registration
and Device Listing
Bench
II
Substantial
Equivalence
510(k)
Bench
Animal
III Safe and Effective PMA
Bench
Animal
Human
*Some Exceptions
PreMarket
Approval
• Must prove the device is safe and effective
• IDE clinical trials needed
• Are your nearest competitor devices
PMAs? Check at FDA > Medical Devices >
Databases > PMAs
Will I Need
Clinical Studies?
• All original PMAs need
clinical studies
• And 10% of all 510(k)s
also need clinical studies
• Conducted under IDE
• Add multiple $$Mi and
years to market!
What are the Strategic
Implications?
Class
Level of
Proof
FDA
Filing*
Size of the
Filing
Fees:
“Retail”
Small Bus
Time**:
to Reply
Total Time
N per
Year**
Changes
After
Approval?
I
Mfg Registration
and Device Listing
10-20 pp $3,382 2-4 weeks NA
Update device
listing
II
Substantial
Equivalence
510(k) 50-200 pp
$4,690
$2,345
3 months
7 months
3,060 File new 510(k)
III
Safe and
Effective
PMA
10,000–
50,000 pp
$234,495
$58,624
6 months
16 months
45
File PMA
Supplement
(2,116/y)
*Exceptions **For 2016
Final Thoughts
Don’t Make These Mistakes!
 “My device has patents, so it can’t be SE”.
 Design your device, get investors, and THEN
get a regulatory strategy.
 Use mfgs inexperienced with FDA.
 Plan for a large % of your sales to be off-label.
 Hide from FDA until you file your submission.
 “I paid the filing fee; FDA owes me approval!”
 Expect FDA to tell you what to do.
 Think that FDA market approval/clearance
assures 3rd party reimbursement.
Regulatory
Wisdom (?)
 The product you submit on is far more than the device you design.
 Remember the two key regulatory approval questions:
 Is it 510(k) or PMA?
 Are clinical trials needed?
 About FDA, remember:
 Attitude: process-driven and professional. Every device is
unsafe and ineffective until proven otherwise.
 Mission: safe and effective medical devices. Not cool, disruptive,
or cheap. They don’t care about your business success.
 Regulatory applications are written by believers and reviewed by
skeptics.
Questions!

More Related Content

What's hot

ASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptxASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptx
AartiVats5
 
validation and verification of medical device.pptx
validation and verification of medical device.pptxvalidation and verification of medical device.pptx
validation and verification of medical device.pptx
GargiVaghela
 
Medical Device Exemption and Post Marketing Survelliance
Medical Device Exemption and Post Marketing SurvellianceMedical Device Exemption and Post Marketing Survelliance
Medical Device Exemption and Post Marketing Survelliance
CSIR-URDIP, NCL Campus, Pune
 
GHTF
GHTFGHTF
GHTF
KDivya11
 
Regulatory approval process for medical Devices
Regulatory approval process for medical DevicesRegulatory approval process for medical Devices
Regulatory approval process for medical Devices
The QCCP
 
510kvs pma slides
510kvs pma slides510kvs pma slides
510kvs pma slides
Tahir Rizvi
 
Medical device clinical evaluation
Medical device clinical evaluationMedical device clinical evaluation
Medical device clinical evaluationMalesh M
 
Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...
Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...
Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...
TGA Australia
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Aakashdeep Raval
 
ISO 14155.pdf
ISO 14155.pdfISO 14155.pdf
ISO 14155.pdf
Zeelshah2258
 
Japan Medical Device Regulatory Approval Process
Japan Medical Device Regulatory Approval ProcessJapan Medical Device Regulatory Approval Process
Japan Medical Device Regulatory Approval Process
Kate Jablonski
 
FDA regulation for medical devices
FDA regulation for medical devicesFDA regulation for medical devices
FDA regulation for medical devices
Simrana Fathima
 
labelling requirements and label claims for dietary supplements in USA
labelling requirements and label claims for dietary supplements in USAlabelling requirements and label claims for dietary supplements in USA
labelling requirements and label claims for dietary supplements in USA
navyasribandaru
 
Clinical investigation and evaluation of medical devices and ivd.pptx
Clinical investigation and evaluation of medical devices and ivd.pptxClinical investigation and evaluation of medical devices and ivd.pptx
Clinical investigation and evaluation of medical devices and ivd.pptx
reechashah2
 
plasma master file in European countries and requirements in letter of intent...
plasma master file in European countries and requirements in letter of intent...plasma master file in European countries and requirements in letter of intent...
plasma master file in European countries and requirements in letter of intent...
Sanjay batra
 
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Akshay Anand
 
NSF certification, Standard for dietary supplement
NSF certification, Standard for dietary supplementNSF certification, Standard for dietary supplement
NSF certification, Standard for dietary supplement
Atul Bhombe
 
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
Medical Devices Regulation (MDR)  2017/745 - Clinical investigationsMedical Devices Regulation (MDR)  2017/745 - Clinical investigations
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
Arete-Zoe, LLC
 
FDA Unique Device Identification (UDI) Overview
FDA Unique Device Identification (UDI) OverviewFDA Unique Device Identification (UDI) Overview
FDA Unique Device Identification (UDI) Overview
Caroline Bloemker, M.S., RAC
 
Ghtf study group 4
Ghtf study group 4Ghtf study group 4
Ghtf study group 4
sangeethapriyas3
 

What's hot (20)

ASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptxASEAN COUNTRIES.pptx
ASEAN COUNTRIES.pptx
 
validation and verification of medical device.pptx
validation and verification of medical device.pptxvalidation and verification of medical device.pptx
validation and verification of medical device.pptx
 
Medical Device Exemption and Post Marketing Survelliance
Medical Device Exemption and Post Marketing SurvellianceMedical Device Exemption and Post Marketing Survelliance
Medical Device Exemption and Post Marketing Survelliance
 
GHTF
GHTFGHTF
GHTF
 
Regulatory approval process for medical Devices
Regulatory approval process for medical DevicesRegulatory approval process for medical Devices
Regulatory approval process for medical Devices
 
510kvs pma slides
510kvs pma slides510kvs pma slides
510kvs pma slides
 
Medical device clinical evaluation
Medical device clinical evaluationMedical device clinical evaluation
Medical device clinical evaluation
 
Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...
Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...
Regulation of In Vitro Diagnostic Medical Devices - Transition to the New IVD...
 
Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.Comparison of Clinical Trial Application requirement of India, USA and Europe.
Comparison of Clinical Trial Application requirement of India, USA and Europe.
 
ISO 14155.pdf
ISO 14155.pdfISO 14155.pdf
ISO 14155.pdf
 
Japan Medical Device Regulatory Approval Process
Japan Medical Device Regulatory Approval ProcessJapan Medical Device Regulatory Approval Process
Japan Medical Device Regulatory Approval Process
 
FDA regulation for medical devices
FDA regulation for medical devicesFDA regulation for medical devices
FDA regulation for medical devices
 
labelling requirements and label claims for dietary supplements in USA
labelling requirements and label claims for dietary supplements in USAlabelling requirements and label claims for dietary supplements in USA
labelling requirements and label claims for dietary supplements in USA
 
Clinical investigation and evaluation of medical devices and ivd.pptx
Clinical investigation and evaluation of medical devices and ivd.pptxClinical investigation and evaluation of medical devices and ivd.pptx
Clinical investigation and evaluation of medical devices and ivd.pptx
 
plasma master file in European countries and requirements in letter of intent...
plasma master file in European countries and requirements in letter of intent...plasma master file in European countries and requirements in letter of intent...
plasma master file in European countries and requirements in letter of intent...
 
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
 
NSF certification, Standard for dietary supplement
NSF certification, Standard for dietary supplementNSF certification, Standard for dietary supplement
NSF certification, Standard for dietary supplement
 
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
Medical Devices Regulation (MDR)  2017/745 - Clinical investigationsMedical Devices Regulation (MDR)  2017/745 - Clinical investigations
Medical Devices Regulation (MDR) 2017/745 - Clinical investigations
 
FDA Unique Device Identification (UDI) Overview
FDA Unique Device Identification (UDI) OverviewFDA Unique Device Identification (UDI) Overview
FDA Unique Device Identification (UDI) Overview
 
Ghtf study group 4
Ghtf study group 4Ghtf study group 4
Ghtf study group 4
 

Similar to FDA Approval for Medical Devices: A Guide for Entrepreneurs | Jim Gustafson | Lunch & Learn

Oct2019 presentation tim grammer 13 feb2019
Oct2019 presentation tim grammer 13 feb2019Oct2019 presentation tim grammer 13 feb2019
Oct2019 presentation tim grammer 13 feb2019
Timothy Grammer
 
FDA 510(k) Submission Tips & Best Practices
FDA 510(k) Submission Tips & Best PracticesFDA 510(k) Submission Tips & Best Practices
FDA 510(k) Submission Tips & Best Practices
Greenlight Guru
 
Medical Device Trials.pptx
Medical Device Trials.pptxMedical Device Trials.pptx
Medical Device Trials.pptx
Mohammad Umar
 
Good clinical practices tutorial- v7.015--shehnaz_june-10_v 3.0
Good clinical practices tutorial- v7.015--shehnaz_june-10_v 3.0Good clinical practices tutorial- v7.015--shehnaz_june-10_v 3.0
Good clinical practices tutorial- v7.015--shehnaz_june-10_v 3.0Shehnaz Vakharia
 
Overview of FDA Issues for Cardiovascular Device Makers
Overview of FDA Issues for Cardiovascular Device MakersOverview of FDA Issues for Cardiovascular Device Makers
Overview of FDA Issues for Cardiovascular Device Makers
Michael Swit
 
UCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
UCSF Life Sciences: Week 7 Devices Resources, Activities and CostsUCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
UCSF Life Sciences: Week 7 Devices Resources, Activities and CostsStanford University
 
regulatory requirements of biologicals.pptx
regulatory requirements of biologicals.pptxregulatory requirements of biologicals.pptx
regulatory requirements of biologicals.pptx
RmakilaKathiresan
 
Medical Device Advertising Law & Regulation
Medical Device Advertising Law & RegulationMedical Device Advertising Law & Regulation
Medical Device Advertising Law & Regulation
Michael Swit
 
Medical Device Advertising Law & Regulation
Medical Device Advertising Law & RegulationMedical Device Advertising Law & Regulation
Medical Device Advertising Law & Regulation
Michael Swit
 
Regulatory submission: Applying GLP in surgical efficacy studies
Regulatory submission: Applying GLP in surgical efficacy studiesRegulatory submission: Applying GLP in surgical efficacy studies
Regulatory submission: Applying GLP in surgical efficacy studies
UBMCanon
 
FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...
Pubrica
 
FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...
Pubrica
 
regulation for combination product and medical devices
regulation for combination product and medical devicesregulation for combination product and medical devices
regulation for combination product and medical devices
SNEHADAS123
 
Regulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usRegulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usVinod Raj
 
FDA Regulatory Considerations for the Biomedical Start-up
FDA Regulatory Considerations for the Biomedical Start-upFDA Regulatory Considerations for the Biomedical Start-up
FDA Regulatory Considerations for the Biomedical Start-up
Michael Swit
 
Using Clinical Studies to Support Claims for 510(k) Medical Devices
Using Clinical Studies to Support Claims for 510(k) Medical DevicesUsing Clinical Studies to Support Claims for 510(k) Medical Devices
Using Clinical Studies to Support Claims for 510(k) Medical Devices
Michael Swit
 
Using Clinical Studies to Support Claims for 510(k) Devices.
Using Clinical Studies to Support Claims for 510(k) Devices.  Using Clinical Studies to Support Claims for 510(k) Devices.
Using Clinical Studies to Support Claims for 510(k) Devices.
Michael Swit
 
Kobridge medical devices registration in South Korea
Kobridge medical devices registration in South KoreaKobridge medical devices registration in South Korea
Kobridge medical devices registration in South Korea
Kobridge Consulting Ltd.
 
Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...
Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...
Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...
Michael Swit
 
Understanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical DevicesUnderstanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical Devices
marchell
 

Similar to FDA Approval for Medical Devices: A Guide for Entrepreneurs | Jim Gustafson | Lunch & Learn (20)

Oct2019 presentation tim grammer 13 feb2019
Oct2019 presentation tim grammer 13 feb2019Oct2019 presentation tim grammer 13 feb2019
Oct2019 presentation tim grammer 13 feb2019
 
FDA 510(k) Submission Tips & Best Practices
FDA 510(k) Submission Tips & Best PracticesFDA 510(k) Submission Tips & Best Practices
FDA 510(k) Submission Tips & Best Practices
 
Medical Device Trials.pptx
Medical Device Trials.pptxMedical Device Trials.pptx
Medical Device Trials.pptx
 
Good clinical practices tutorial- v7.015--shehnaz_june-10_v 3.0
Good clinical practices tutorial- v7.015--shehnaz_june-10_v 3.0Good clinical practices tutorial- v7.015--shehnaz_june-10_v 3.0
Good clinical practices tutorial- v7.015--shehnaz_june-10_v 3.0
 
Overview of FDA Issues for Cardiovascular Device Makers
Overview of FDA Issues for Cardiovascular Device MakersOverview of FDA Issues for Cardiovascular Device Makers
Overview of FDA Issues for Cardiovascular Device Makers
 
UCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
UCSF Life Sciences: Week 7 Devices Resources, Activities and CostsUCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
UCSF Life Sciences: Week 7 Devices Resources, Activities and Costs
 
regulatory requirements of biologicals.pptx
regulatory requirements of biologicals.pptxregulatory requirements of biologicals.pptx
regulatory requirements of biologicals.pptx
 
Medical Device Advertising Law & Regulation
Medical Device Advertising Law & RegulationMedical Device Advertising Law & Regulation
Medical Device Advertising Law & Regulation
 
Medical Device Advertising Law & Regulation
Medical Device Advertising Law & RegulationMedical Device Advertising Law & Regulation
Medical Device Advertising Law & Regulation
 
Regulatory submission: Applying GLP in surgical efficacy studies
Regulatory submission: Applying GLP in surgical efficacy studiesRegulatory submission: Applying GLP in surgical efficacy studies
Regulatory submission: Applying GLP in surgical efficacy studies
 
FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...
 
FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...FDA classify Medical Devices and how to report device problems A Systematic R...
FDA classify Medical Devices and how to report device problems A Systematic R...
 
regulation for combination product and medical devices
regulation for combination product and medical devicesregulation for combination product and medical devices
regulation for combination product and medical devices
 
Regulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in usRegulatory approval process for invitro diagnostics in us
Regulatory approval process for invitro diagnostics in us
 
FDA Regulatory Considerations for the Biomedical Start-up
FDA Regulatory Considerations for the Biomedical Start-upFDA Regulatory Considerations for the Biomedical Start-up
FDA Regulatory Considerations for the Biomedical Start-up
 
Using Clinical Studies to Support Claims for 510(k) Medical Devices
Using Clinical Studies to Support Claims for 510(k) Medical DevicesUsing Clinical Studies to Support Claims for 510(k) Medical Devices
Using Clinical Studies to Support Claims for 510(k) Medical Devices
 
Using Clinical Studies to Support Claims for 510(k) Devices.
Using Clinical Studies to Support Claims for 510(k) Devices.  Using Clinical Studies to Support Claims for 510(k) Devices.
Using Clinical Studies to Support Claims for 510(k) Devices.
 
Kobridge medical devices registration in South Korea
Kobridge medical devices registration in South KoreaKobridge medical devices registration in South Korea
Kobridge medical devices registration in South Korea
 
Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...
Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...
Ensuring FDA Regulatory Success for Biomedical Companies -- Key Lessons for S...
 
Understanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical DevicesUnderstanding FDA Requirements Medical Devices
Understanding FDA Requirements Medical Devices
 

More from UCICove

Build Trust, Foster Innovation
Build Trust, Foster InnovationBuild Trust, Foster Innovation
Build Trust, Foster Innovation
UCICove
 
Intellectual Property, Contracts, and Websites…Oh My | Stephanie Pottick | Lu...
Intellectual Property, Contracts, and Websites…Oh My | Stephanie Pottick | Lu...Intellectual Property, Contracts, and Websites…Oh My | Stephanie Pottick | Lu...
Intellectual Property, Contracts, and Websites…Oh My | Stephanie Pottick | Lu...
UCICove
 
Venture Financings 101 (SAFEs, Convertible Notes, Seed and Series A) | Bardia...
Venture Financings 101 (SAFEs, Convertible Notes, Seed and Series A) | Bardia...Venture Financings 101 (SAFEs, Convertible Notes, Seed and Series A) | Bardia...
Venture Financings 101 (SAFEs, Convertible Notes, Seed and Series A) | Bardia...
UCICove
 
Diversity, Inclusion & Belonging: What’s the Difference and Why Does it Matte...
Diversity, Inclusion & Belonging: What’s the Difference and Why Does it Matte...Diversity, Inclusion & Belonging: What’s the Difference and Why Does it Matte...
Diversity, Inclusion & Belonging: What’s the Difference and Why Does it Matte...
UCICove
 
Creating Customer Loyalty (And How to Keep It!) | Steve Blanc | Lunch & Learn
Creating Customer Loyalty (And How to Keep It!) | Steve Blanc | Lunch & LearnCreating Customer Loyalty (And How to Keep It!) | Steve Blanc | Lunch & Learn
Creating Customer Loyalty (And How to Keep It!) | Steve Blanc | Lunch & Learn
UCICove
 
The Art and Science of a Compelling Equity Story
The Art and Science of a Compelling Equity StoryThe Art and Science of a Compelling Equity Story
The Art and Science of a Compelling Equity Story
UCICove
 
Using Your Company Brand in Your HR Practice
Using Your Company Brand in Your HR PracticeUsing Your Company Brand in Your HR Practice
Using Your Company Brand in Your HR Practice
UCICove
 
Ten Pointers for the Perfect Pitch
Ten Pointers for the Perfect PitchTen Pointers for the Perfect Pitch
Ten Pointers for the Perfect Pitch
UCICove
 
Killing Cats Leads to Rats: Mitigating the Unintended Consequences of Busines...
Killing Cats Leads to Rats: Mitigating the Unintended Consequences of Busines...Killing Cats Leads to Rats: Mitigating the Unintended Consequences of Busines...
Killing Cats Leads to Rats: Mitigating the Unintended Consequences of Busines...
UCICove
 
Transform Your Audience From One-Time Consumers to Loyal Fans Using Emotional...
Transform Your Audience From One-Time Consumers to Loyal Fans Using Emotional...Transform Your Audience From One-Time Consumers to Loyal Fans Using Emotional...
Transform Your Audience From One-Time Consumers to Loyal Fans Using Emotional...
UCICove
 
Time to Level Up! Learn the Eight Strategic Steps Your Company Needs to Shift...
Time to Level Up! Learn the Eight Strategic Steps Your Company Needs to Shift...Time to Level Up! Learn the Eight Strategic Steps Your Company Needs to Shift...
Time to Level Up! Learn the Eight Strategic Steps Your Company Needs to Shift...
UCICove
 
The Fourth Industrial Revolution ... Are You Ready For It? | Has Patel | Lunc...
The Fourth Industrial Revolution ... Are You Ready For It? | Has Patel | Lunc...The Fourth Industrial Revolution ... Are You Ready For It? | Has Patel | Lunc...
The Fourth Industrial Revolution ... Are You Ready For It? | Has Patel | Lunc...
UCICove
 
Disruptive Scalability – Leap Growth for Exponential Returns | Scott Hamilton...
Disruptive Scalability – Leap Growth for Exponential Returns | Scott Hamilton...Disruptive Scalability – Leap Growth for Exponential Returns | Scott Hamilton...
Disruptive Scalability – Leap Growth for Exponential Returns | Scott Hamilton...
UCICove
 
Understanding How Venture Capital Works | Kirsten Leute and John Lee | Lunch ...
Understanding How Venture Capital Works | Kirsten Leute and John Lee | Lunch ...Understanding How Venture Capital Works | Kirsten Leute and John Lee | Lunch ...
Understanding How Venture Capital Works | Kirsten Leute and John Lee | Lunch ...
UCICove
 
Identifying IP Assets and What Should Be Done with Them | Doug Hahn and Salil...
Identifying IP Assets and What Should Be Done with Them | Doug Hahn and Salil...Identifying IP Assets and What Should Be Done with Them | Doug Hahn and Salil...
Identifying IP Assets and What Should Be Done with Them | Doug Hahn and Salil...
UCICove
 
Using the Power of Story to Create Radically Clear Marketing | Kevin Krusiew...
 Using the Power of Story to Create Radically Clear Marketing | Kevin Krusiew... Using the Power of Story to Create Radically Clear Marketing | Kevin Krusiew...
Using the Power of Story to Create Radically Clear Marketing | Kevin Krusiew...
UCICove
 
An Introduction to Cryptocurrency Funds | Timothy Spangler | Lunch & Learn
An Introduction to Cryptocurrency Funds | Timothy Spangler | Lunch & LearnAn Introduction to Cryptocurrency Funds | Timothy Spangler | Lunch & Learn
An Introduction to Cryptocurrency Funds | Timothy Spangler | Lunch & Learn
UCICove
 
Wild Card Management: How to Predict and Leverage a Disruptive Future | Jim ...
 Wild Card Management: How to Predict and Leverage a Disruptive Future | Jim ... Wild Card Management: How to Predict and Leverage a Disruptive Future | Jim ...
Wild Card Management: How to Predict and Leverage a Disruptive Future | Jim ...
UCICove
 
The Fundable Startup | Fred M. Haney | Lunch & Learn
The Fundable Startup | Fred M. Haney | Lunch & LearnThe Fundable Startup | Fred M. Haney | Lunch & Learn
The Fundable Startup | Fred M. Haney | Lunch & Learn
UCICove
 
Persuade Investors with a Story | Henry DeVries | Lunch & Learn
Persuade Investors with a Story | Henry DeVries | Lunch & LearnPersuade Investors with a Story | Henry DeVries | Lunch & Learn
Persuade Investors with a Story | Henry DeVries | Lunch & Learn
UCICove
 

More from UCICove (20)

Build Trust, Foster Innovation
Build Trust, Foster InnovationBuild Trust, Foster Innovation
Build Trust, Foster Innovation
 
Intellectual Property, Contracts, and Websites…Oh My | Stephanie Pottick | Lu...
Intellectual Property, Contracts, and Websites…Oh My | Stephanie Pottick | Lu...Intellectual Property, Contracts, and Websites…Oh My | Stephanie Pottick | Lu...
Intellectual Property, Contracts, and Websites…Oh My | Stephanie Pottick | Lu...
 
Venture Financings 101 (SAFEs, Convertible Notes, Seed and Series A) | Bardia...
Venture Financings 101 (SAFEs, Convertible Notes, Seed and Series A) | Bardia...Venture Financings 101 (SAFEs, Convertible Notes, Seed and Series A) | Bardia...
Venture Financings 101 (SAFEs, Convertible Notes, Seed and Series A) | Bardia...
 
Diversity, Inclusion & Belonging: What’s the Difference and Why Does it Matte...
Diversity, Inclusion & Belonging: What’s the Difference and Why Does it Matte...Diversity, Inclusion & Belonging: What’s the Difference and Why Does it Matte...
Diversity, Inclusion & Belonging: What’s the Difference and Why Does it Matte...
 
Creating Customer Loyalty (And How to Keep It!) | Steve Blanc | Lunch & Learn
Creating Customer Loyalty (And How to Keep It!) | Steve Blanc | Lunch & LearnCreating Customer Loyalty (And How to Keep It!) | Steve Blanc | Lunch & Learn
Creating Customer Loyalty (And How to Keep It!) | Steve Blanc | Lunch & Learn
 
The Art and Science of a Compelling Equity Story
The Art and Science of a Compelling Equity StoryThe Art and Science of a Compelling Equity Story
The Art and Science of a Compelling Equity Story
 
Using Your Company Brand in Your HR Practice
Using Your Company Brand in Your HR PracticeUsing Your Company Brand in Your HR Practice
Using Your Company Brand in Your HR Practice
 
Ten Pointers for the Perfect Pitch
Ten Pointers for the Perfect PitchTen Pointers for the Perfect Pitch
Ten Pointers for the Perfect Pitch
 
Killing Cats Leads to Rats: Mitigating the Unintended Consequences of Busines...
Killing Cats Leads to Rats: Mitigating the Unintended Consequences of Busines...Killing Cats Leads to Rats: Mitigating the Unintended Consequences of Busines...
Killing Cats Leads to Rats: Mitigating the Unintended Consequences of Busines...
 
Transform Your Audience From One-Time Consumers to Loyal Fans Using Emotional...
Transform Your Audience From One-Time Consumers to Loyal Fans Using Emotional...Transform Your Audience From One-Time Consumers to Loyal Fans Using Emotional...
Transform Your Audience From One-Time Consumers to Loyal Fans Using Emotional...
 
Time to Level Up! Learn the Eight Strategic Steps Your Company Needs to Shift...
Time to Level Up! Learn the Eight Strategic Steps Your Company Needs to Shift...Time to Level Up! Learn the Eight Strategic Steps Your Company Needs to Shift...
Time to Level Up! Learn the Eight Strategic Steps Your Company Needs to Shift...
 
The Fourth Industrial Revolution ... Are You Ready For It? | Has Patel | Lunc...
The Fourth Industrial Revolution ... Are You Ready For It? | Has Patel | Lunc...The Fourth Industrial Revolution ... Are You Ready For It? | Has Patel | Lunc...
The Fourth Industrial Revolution ... Are You Ready For It? | Has Patel | Lunc...
 
Disruptive Scalability – Leap Growth for Exponential Returns | Scott Hamilton...
Disruptive Scalability – Leap Growth for Exponential Returns | Scott Hamilton...Disruptive Scalability – Leap Growth for Exponential Returns | Scott Hamilton...
Disruptive Scalability – Leap Growth for Exponential Returns | Scott Hamilton...
 
Understanding How Venture Capital Works | Kirsten Leute and John Lee | Lunch ...
Understanding How Venture Capital Works | Kirsten Leute and John Lee | Lunch ...Understanding How Venture Capital Works | Kirsten Leute and John Lee | Lunch ...
Understanding How Venture Capital Works | Kirsten Leute and John Lee | Lunch ...
 
Identifying IP Assets and What Should Be Done with Them | Doug Hahn and Salil...
Identifying IP Assets and What Should Be Done with Them | Doug Hahn and Salil...Identifying IP Assets and What Should Be Done with Them | Doug Hahn and Salil...
Identifying IP Assets and What Should Be Done with Them | Doug Hahn and Salil...
 
Using the Power of Story to Create Radically Clear Marketing | Kevin Krusiew...
 Using the Power of Story to Create Radically Clear Marketing | Kevin Krusiew... Using the Power of Story to Create Radically Clear Marketing | Kevin Krusiew...
Using the Power of Story to Create Radically Clear Marketing | Kevin Krusiew...
 
An Introduction to Cryptocurrency Funds | Timothy Spangler | Lunch & Learn
An Introduction to Cryptocurrency Funds | Timothy Spangler | Lunch & LearnAn Introduction to Cryptocurrency Funds | Timothy Spangler | Lunch & Learn
An Introduction to Cryptocurrency Funds | Timothy Spangler | Lunch & Learn
 
Wild Card Management: How to Predict and Leverage a Disruptive Future | Jim ...
 Wild Card Management: How to Predict and Leverage a Disruptive Future | Jim ... Wild Card Management: How to Predict and Leverage a Disruptive Future | Jim ...
Wild Card Management: How to Predict and Leverage a Disruptive Future | Jim ...
 
The Fundable Startup | Fred M. Haney | Lunch & Learn
The Fundable Startup | Fred M. Haney | Lunch & LearnThe Fundable Startup | Fred M. Haney | Lunch & Learn
The Fundable Startup | Fred M. Haney | Lunch & Learn
 
Persuade Investors with a Story | Henry DeVries | Lunch & Learn
Persuade Investors with a Story | Henry DeVries | Lunch & LearnPersuade Investors with a Story | Henry DeVries | Lunch & Learn
Persuade Investors with a Story | Henry DeVries | Lunch & Learn
 

Recently uploaded

Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 

Recently uploaded (20)

Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 

FDA Approval for Medical Devices: A Guide for Entrepreneurs | Jim Gustafson | Lunch & Learn

  • 1. FDA Approval for Medical Devices: A Guide for Entrepreneurs Jim Gustafson, Expert in Residence UCI Applied Innovation Friday 21 April 2017
  • 2. Today’s Outline 1. Our Purpose 2. Who Am I? 3. Basics of Device Regulation in the US 4. Developing a Regulatory Strategy 5. Final Thoughts 6. Questions
  • 4. What Do Potential Investors Want to Know?  What is your approval pathway?  How long will it take?  How much will it cost?  How likely is success?
  • 5. Without A Viable Strategy for Regulatory Approval, You Will  Investors will dismiss you.  FDA will be a roadblock to you.  Employees will lose faith in you.  Potential customers will find someone else to meet their needs.
  • 6. Today’s Objectives Provide a basic scaffold to better understand the regulatory realities and options for your own situation. Not to answer all your questions or define a reg strategy for you. A reg strategy must be custom-fit to your product, business plan, customer, competitive landscape, etc.
  • 7.
  • 8. Academics BS Biology 1977 University of Minnesota MS Biology 1978 University of California, Irvine MA Management 1986 University of Redlands Mini-MBA 2011 Carnegie-Mellon University, Pittsburgh
  • 9. Professional  35+ years in the medical device industry • Class II and III • Regulatory Strat, Clin Science, Executive • 40-plus 510(k)s, PMAs, PMAS, IDEs, CE Marks • 3 FDA Advisory Panel presentations • 20-plus multi-center clinical trials in NA and EU  Last Company: from pre-sales and no approvals to $80M sales and 20 approvals. In 14 yrs. Sold in 2008 for $361 M.  Last Title: SVP, Clinical Science and Regulatory Affairs  Now: Semi-retired indy consultant to med device cos. • EiR with UCI Applied Innovations • OCTANe panelist and LauchPad consultant • Undergrad Mentor, UCI Ayala School of BioSci
  • 10. 3. Basics of Medical Device Regulation in the US
  • 11. The Law Requires • US Medical Devices must be proven “safe and effective” based on “valid scientific evidence”. • Compare to US Drugs: must be proven “safe and effective” based on “well- controlled clinical studies”. • Compare to Devices in the EU: must be proven “safe and functions as designed”.
  • 12. Medical Devices are Regulated Based on Risk Class Requirements I 1. General Controls II 1. General Controls 2. Device-Specific Special Controls 3. Premarket Notification, aka 510(k) III 1. General Controls 2. Device-Specific Special Controls 3. Premarket Approval, aka PMA
  • 13. Medical Devices are Regulated Based on Device Risk Class Requirements I 1. General Controls II 1. General Controls 2. Device-Specific Special Controls 3. Premarket Notification, aka 510(k) III 1. General Controls 2. Device-Specific Special Controls 3. Premarket Approval, aka PMA
  • 14. General Controls • Adulteration • Misbranding • Device registration and listing • Records and reports • Good Manufacturing Practices (GMPs, aka Quality System Regulation, or QSR)
  • 15. Medical Devices are Regulated Based on Device Risk Class Requirements I 1. General Controls II 1. General Controls 2. Device-Specific Special Controls 3. Premarket Notification, AKA 510(k) III 1. General Controls 2. Device-Specific Special Controls 3. Premarket Approval, AKA PMA
  • 16. Special Controls Include  Independent Standards:  ISO, ANSI, IEC, ASTM, etc.  Horizontal Standards  Vertical Standards  FDA Guidance Documents If any of these apply to your product, use them, or be prepared to explain why not, and what you used instead, and why.
  • 17. 4. How to Develop a Successful Regulatory Approval Strategy
  • 18. At some point you should probably talk to your friendly neighborhood regulatory consultant. But you can figure out many of the key elements yourself!
  • 19. How? Ask the Right Questions! 1. Is my product a medical device? 2. What Class is my product in? 3. What is my pathway to approval? 4. Will clinical studies be needed? 5. What are the strategic implications of the pathway?
  • 20. Is My Product a Medical Device? An instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, component, or accessory which is: 1. Intended to diagnosis disease or other conditions; or 2. Intended to cure, mitigate, treat, or prevent disease; or 3. Intended to affect the structure or any function of the body; 4. And which does not achieve any of its primary intended purposes through chemical action, 5. And does not depend on being metabolized to achieve them.
  • 21. The Border May be Set by Claims and Intended Use Example: A wearable that counts footsteps or calories, but claims no medical benefit from doing so, is NOT a medical device. The same product doing the same thing but with the claim that doing so helps the user lose weight or lower blood pressure IS a medical device.
  • 22. What Class is My Product? • Go to FDA > Medical Devices > Data Bases > Product Classification (https://www.accessdata.fda.gov/scripts/cdrh/cf docs/cfPCD/PCDSimpleSearch.cfm) • Type in the name of your product. • Review the listing. • Iterate until you find the most accurate description.
  • 27.
  • 28. What Is My Approval Pathway? Class Level of Proof FDA Filing* Testing Needed* I Mfg Registration and Device Listing Bench II Substantial Equivalence 510(k) Bench Animal III Safe and Effective PMA Bench Animal Human *Some Exceptions
  • 29. Is My Device a 510(k)? Almost all Class II devices are! But how to know? • Check out similar devices on the FDA Product Listing page • Find 510(k)s for similar devices at FDA > Medical Devices > Database > 510(k)s • Is there a device, itself under 510(k), to which you can prove substantial equivalence (SE)? • You can’t claim SE to a PMA device.
  • 30. What Makes for SE? (1/2) Compared to the Proposed Predicate Device: • Same intended use and same technological characteristics; or • Same intended use and different technological characteristics, but that do not raise new questions of safety and effectiveness, with supporting evidence that the new device is at least as safe and effective as the predicate.
  • 31. What Makes for SE? (2/2) SE does not mean the 2 devices are identical. SE is judged base on intended use, design, energy used or delivered, materials, chemical composition, manufacturing process, performance, safety, effectiveness, labeling, biocompatibility, standards, etc.
  • 32. SE is Kind of a Black Art • The closer to your proposed predicate on each of these, the more likely you will succeed. • But there is no hard rule, guidance! • FDA will not tell you; you must make your case in a 510(k) filing! • In FDA’s response, you will know. • One key: how far is your predicate from its? SE
  • 33. If Not 510(k), Then It’s PMA Class Level of Proof FDA Filing* Testing Needed* I Mfg Registration and Device Listing Bench II Substantial Equivalence 510(k) Bench Animal III Safe and Effective PMA Bench Animal Human *Some Exceptions
  • 34. PreMarket Approval • Must prove the device is safe and effective • IDE clinical trials needed • Are your nearest competitor devices PMAs? Check at FDA > Medical Devices > Databases > PMAs
  • 35. Will I Need Clinical Studies? • All original PMAs need clinical studies • And 10% of all 510(k)s also need clinical studies • Conducted under IDE • Add multiple $$Mi and years to market!
  • 36. What are the Strategic Implications? Class Level of Proof FDA Filing* Size of the Filing Fees: “Retail” Small Bus Time**: to Reply Total Time N per Year** Changes After Approval? I Mfg Registration and Device Listing 10-20 pp $3,382 2-4 weeks NA Update device listing II Substantial Equivalence 510(k) 50-200 pp $4,690 $2,345 3 months 7 months 3,060 File new 510(k) III Safe and Effective PMA 10,000– 50,000 pp $234,495 $58,624 6 months 16 months 45 File PMA Supplement (2,116/y) *Exceptions **For 2016
  • 38. Don’t Make These Mistakes!  “My device has patents, so it can’t be SE”.  Design your device, get investors, and THEN get a regulatory strategy.  Use mfgs inexperienced with FDA.  Plan for a large % of your sales to be off-label.  Hide from FDA until you file your submission.  “I paid the filing fee; FDA owes me approval!”  Expect FDA to tell you what to do.  Think that FDA market approval/clearance assures 3rd party reimbursement.
  • 39. Regulatory Wisdom (?)  The product you submit on is far more than the device you design.  Remember the two key regulatory approval questions:  Is it 510(k) or PMA?  Are clinical trials needed?  About FDA, remember:  Attitude: process-driven and professional. Every device is unsafe and ineffective until proven otherwise.  Mission: safe and effective medical devices. Not cool, disruptive, or cheap. They don’t care about your business success.  Regulatory applications are written by believers and reviewed by skeptics.
  • 40.